Arrive AI, Inc. – Key Investor Update from Restated Q3 2025 10-Q/A Filing

Overview

Arrive AI, Inc. has filed an Amendment No. 1 to its Quarterly Report on Form 10-Q/A for the period ended September 30, 2025. This restatement follows the original filing on November 14, 2025, and addresses significant accounting errors identified post-filing. The company is listed on The Nasdaq Stock Market LLC under the ticker symbol ARAI.

Key Points from the Restatement

• Restatement Triggered by Accounting Errors: Management, in consultation with its independent registered public accounting firm, discovered errors related to hybrid financial instruments issued in connection with the Securities Purchase Agreement dated March 21, 2025, with Streeterville Capital, LLC. Specifically, embedded conversion features were not bifurcated and accounted for as derivative liabilities at fair value, as required by ASC 815.
• Debt Discount and Issuance Costs: The original issue discount and debt issuance costs related to these instruments were not properly accreted using the effective interest method over the correct period.
• Audit Committee Actions: The Audit Committee, together with management, concluded that the previously issued financial statements should no longer be relied upon. The restated financials reflect these corrections.
• Financial Statement Changes: The following items were amended and restated:
  • Condensed balance sheet as of September 30, 2025
  • Condensed statements of operations and comprehensive loss
  • Condensed statements of stockholders’ equity (deficit)
  • Condensed statements of cash flows for the three and nine months ended September 30, 2025
  • Related notes to the condensed financial statements
• Management’s Discussion and Analysis: Updated to reflect the impact of the restatement on financial condition, results of operations, and liquidity.
• Controls and Procedures: Management revised its conclusions regarding the effectiveness of disclosure controls and procedures and internal controls over financial reporting (ICFR), including disclosure of a material weakness identified in connection with the restatement.
• Sarbanes-Oxley Certifications: Updated certifications from the principal executive officer and principal financial officer pursuant to Sections 302 and 906 of the Sarbanes-Oxley Act of 2002.

Financial Highlights

• Stockholders’ Equity:
  • As of September 30, 2025: \$5,678,445
  • As of December 31, 2024: (\$11,175) (deficit)
• Total Assets:
  • September 30, 2025: \$9,709,064
  • December 31, 2024: \$987,788
• Common Stock:
  • Authorized: 100,000,000 shares
  • Issued and Outstanding as of September 30, 2025: 34,233,087 issued, 34,213,387 outstanding
  • Issued and Outstanding as of December 31, 2024: 29,120,905 issued and outstanding
  • Par value: \$0.0002 per share
• Treasury Stock: As of September 30, 2025, 19,700 shares at cost of \$74,743
• Revenue: For the nine months ended September 30, 2025, revenue from contracts with customers (excluding assessed taxes): \$48,175
• Research & Development Expense: For the quarter ended September 30, 2024: \$7,940

Important Shareholder Information

• Restatement is Material and Price Sensitive: The restatement involves corrections to the accounting treatment of hybrid financial instruments and derivative liabilities, which materially affect the company’s financial statements, stockholders’ equity, and reported results. Investors should note the identification of a material weakness in internal controls over financial reporting, which could impact confidence in future reporting accuracy.
• Potential Impact on Share Price: The correction of these errors and disclosure of a material weakness could influence market perception and valuation, especially given the increase in stockholders’ equity and total assets post-restatement. The company’s transition from a deficit to a positive equity position may be viewed favorably, but the internal controls issue warrants caution.
• Company Status:
  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company
  • Not a shell company
• SEC Compliance: Arrive AI, Inc. has been compliant with SEC filing and interactive data requirements for at least the past 90 days.

Background and Next Steps

The company’s management and audit committee have determined that previous financial statements should not be relied upon. Investors should refer to Note 1 in the unaudited condensed financial statements for more details on the restatement’s impact. Except as described in the restatement, no other disclosures from the original filing have been amended, and this 10-Q/A speaks as of the original filing date.

Disclaimer

The information presented in this article is based on Arrive AI, Inc.’s amended and restated Form 10-Q/A for the period ended September 30, 2025. This article is for informational purposes only and does not constitute investment advice. Investors should perform their own due diligence and consult with financial advisors before making investment decisions. The restatement may materially affect the company’s financial position and share price, and future filings may further impact investor sentiment.